Price T Rowe Associates Inc I Bio, Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
About iBio, Inc.
- Ticker IBIO
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,006,580
- Market Cap $24M
- Description
- iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...